Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ukai

Showing results (41-50 of 132) with videos related to

Pageof 14
Sort By:
European Journal of Pharmacology|August 16, 1991
[D-Ala2,NMePhe4,Gly-ol5]enkephalin, but not [D-Pen2,L-Pen5]enkephalin, specifically inhibits behaviors induced by the dopamine D2 agonist RU 24213T Toyoshi, M Ukai, T Kameyama
Brain Research|October 22, 1993
Dynorphin A-(1-13) attenuates basal forebrain-lesion-induced amnesia in ratsM Ukai, T Kobayashi, T Kameyama
Pharmacology, Biochemistry, and Behavior|March 1, 1989
Inhibition of drinking by naltrexone in the rat: interaction with the dopamine D-1 antagonist SCH 23390 and the D-2 antagonist sulpirideM Ukai, S Nakayama, T Kameyama
Neuropharmacology|October 1, 1989
Multi-dimensional analysis of behavior in mice treated with the delta opioid agonists DADL (D-Ala2-D-Leu5-enkephalin) and DPLPE (D-Pen2-L-Pen5-enkephalin)M Ukai, T Toyoshi, T Kameyama
Neuropharmacology|October 1, 1993
DAMGO ([D-Ala2,NMePhe4,Gly-ol]enkephalin), but not DPLPE ([D-Pen2,L- Pen5]enkephalin), specifically inhibits methamphetamine-induced behavioral responses in the mouseM Ukai, T Toyoshi, T Kameyama
Endocrinology|May 1, 1977
Effect of somatostatin on neurotensin-induced glucagon release and hyperglycemiaM Ukai, I Inoue, T Itatsu
European Journal of Pharmacology|December 29, 1995
Intrastriatal injection of opioid receptor agonists inhibits apomorphine-induced behavior in 6-hydroxydopamine-treated miceT Toyoshi, M Ukai, T Kameyama
Pharmacology, Biochemistry, and Behavior|August 1, 1992
Dynorphin A(1-13) preferentially inhibits behaviors induced by the D2 dopamine agonist RU 24213 but not by the D1 dopamine agonist SK&F 38393M Ukai, T Toyoshi, T Kameyama
European Journal of Pharmacology|May 17, 2000
Effects of endomorphins-1 and -2, endogenous mu-opioid receptor agonists, on spontaneous alternation performance in miceM Ukai, Y Watanabe, T Kameyama
European Journal of Pharmacology|June 12, 2001
Endomorphins 1 and 2, endogenous mu-opioid receptor agonists, impair passive avoidance learning in miceM Ukai, Y Watanabe, T Kameyama
Pageof 14

Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
European Journal of Pharmacology|August 16, 1991
[D-Ala2,NMePhe4,Gly-ol5]enkephalin, but not [D-Pen2,L-Pen5]enkephalin, specifically inhibits behaviors induced by the dopamine D2 agonist RU 24213T Toyoshi, M Ukai, T Kameyama
Brain Research|October 22, 1993
Dynorphin A-(1-13) attenuates basal forebrain-lesion-induced amnesia in ratsM Ukai, T Kobayashi, T Kameyama
Pharmacology, Biochemistry, and Behavior|March 1, 1989
Inhibition of drinking by naltrexone in the rat: interaction with the dopamine D-1 antagonist SCH 23390 and the D-2 antagonist sulpirideM Ukai, S Nakayama, T Kameyama
Neuropharmacology|October 1, 1989
Multi-dimensional analysis of behavior in mice treated with the delta opioid agonists DADL (D-Ala2-D-Leu5-enkephalin) and DPLPE (D-Pen2-L-Pen5-enkephalin)M Ukai, T Toyoshi, T Kameyama
Neuropharmacology|October 1, 1993
DAMGO ([D-Ala2,NMePhe4,Gly-ol]enkephalin), but not DPLPE ([D-Pen2,L- Pen5]enkephalin), specifically inhibits methamphetamine-induced behavioral responses in the mouseM Ukai, T Toyoshi, T Kameyama
Endocrinology|May 1, 1977
Effect of somatostatin on neurotensin-induced glucagon release and hyperglycemiaM Ukai, I Inoue, T Itatsu
European Journal of Pharmacology|December 29, 1995
Intrastriatal injection of opioid receptor agonists inhibits apomorphine-induced behavior in 6-hydroxydopamine-treated miceT Toyoshi, M Ukai, T Kameyama
Pharmacology, Biochemistry, and Behavior|August 1, 1992
Dynorphin A(1-13) preferentially inhibits behaviors induced by the D2 dopamine agonist RU 24213 but not by the D1 dopamine agonist SK&F 38393M Ukai, T Toyoshi, T Kameyama
European Journal of Pharmacology|May 17, 2000
Effects of endomorphins-1 and -2, endogenous mu-opioid receptor agonists, on spontaneous alternation performance in miceM Ukai, Y Watanabe, T Kameyama
European Journal of Pharmacology|June 12, 2001
Endomorphins 1 and 2, endogenous mu-opioid receptor agonists, impair passive avoidance learning in miceM Ukai, Y Watanabe, T Kameyama
Pageof 14